Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0002014866-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | INDV | Preblick Ryan | CFO | M - OptEx | — | +86.9K | 317.3K | +38% | — |
| D | 2026-03-05 | 2026-03-03 | INDV | Preblick Ryan | CFO | F - Tax | $31.98 | -87.6K | 230.3K | -28% | -$2.80M |
| D | 2026-03-05 | 2026-03-03 | INDV | Preblick Ryan | CFO | M - OptEx | — | -113.5K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | M | A | 86,949 | — | 317,292 | D | — | — | (F2) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period. (F3) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-03 | F | D | 87,597 | $31.98 | 230,343 | D | — | — | (F1) In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting Person on March 3, 2021. These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations. |
| 3 | Derivative | Performance Stock Units | 2026-03-03 | M | D | 113,510 | — | 0 | D | $0.00 · 2028-03-03 to — | 113,510 Common Stock | (F3) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. (F2) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period. |